SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Argus Research Upgrades Biogen to Buy From Hold, Sets $280 Target

Valid market news retained in the public archive without immediate LiveCast distribution.

BIIB

Related stories